Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000818570 | SCV000959190 | pathogenic | Thrombophilia due to protein C deficiency, autosomal dominant | 2024-02-27 | criteria provided, single submitter | clinical testing | This sequence change affects a donor splice site in intron 5 of the PROC gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in PROC are known to be pathogenic (PMID: 17152060). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individuals with protein C deficiency (PMID: 9840027, 22627591). ClinVar contains an entry for this variant (Variation ID: 661205). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Prevention |
RCV004731041 | SCV005337639 | likely pathogenic | PROC-related disorder | 2024-05-23 | no assertion criteria provided | clinical testing | The PROC c.400+1G>A variant is predicted to disrupt the GT donor site and interfere with normal splicing. To our knowledge this variant has not been reported in literature. This variant has not been reported in a large population database, indicating this variant is rare. Variants that disrupt the consensus splice donor site in PROC are expected to be pathogenic. This variant is interpreted as likely pathogenic. |